Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWN109 in Chinese Non-Diabetic Participants With Overweight or Obesity
NCT07787728Phase 1Completed
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MWN109 in obesity (5 arms), sponsored by Shanghai Minwei Biotechnology Co., Ltd. Primary endpoint: Incidence of adverse events and serious adverse events. Started Jul 2025; status: completed.
02
Drugs
MWN109
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07787728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07787728.